Coastlands Capital LP's Form 4 filing
Pasithea Therapeutics Corp.KTTA · filed Nov 17, 2026
- Accession no.
- 0001104659-26-129251
- Filed
- Nov 17, 2026, 8:42 PM ET
- Trade date
- Nov 13-17, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $805.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coastlands Capital LPCIK 0002068530 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Common Stock | PPurchaseAcquired | +209,431 | $0.4956 | +$103,794 | 4,044,466 | Indirect | |
| Nov 16, 2026 | Common Stock | PPurchaseAcquired | +583,083 | $0.4989 | +$290,900.11 | 4,627,549 | Indirect | |
| Nov 17, 2026 | Common Stock | PPurchaseAcquired | +875,000 | $0.47 | +$411,250 | 5,502,549 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.